Emerging roles of allosteric modulators in the regulation of protein‐protein interactions (PPIs): A new paradigm for PPI drug discovery

Functional organization of the yeast proteome by systematic analysis of protein complexes

Gavin, A., Böesche, M., Krause, R., Grandi, P., Marzioch, M., Bauer, A., Schultz, J., Rick, J. M., Michon, A., Cruciat, C., et al. (2002) · Nature · doi:10.1038/415141a · Cited by 4,729 · see citing works

Microtubules as a target for anticancer drugs

Jordan, M. A., & Wilson, L. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1317 · Cited by 4,534 · see citing works

Promotion of microtubule assembly in vitro by taxol

SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600 · see citing works

Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.

Bredt, D. S., & Snyder, S. H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.682 · Cited by 3,308 · see citing works

Nitric oxide synthases: Roles, tolls, and controls

Nathan, C., & Xie, Q. W. (1994) · Cell · doi:10.1016/0092-8674(94)90266-6 · Cited by 2,920 · see citing works

Towards a proteome-scale map of the human protein–protein interaction network

Rual, J.-F. M., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N., Berriz, G. F., Gibbons, F. D., Dreze, M., Ayivi-Guedehoussou, N., et al. (2005) · Nature · doi:10.1038/nature04209 · Cited by 2,904 · see citing works

A subcellular map of the human proteome

Thul, P. J., Åkesson, L., Wiking, M., Mahdessian, D., Geladaki, A., Ait Blal, H., Alm, T., Asplund, A., Björk, L., Breckels, L. M., et al. (2017) · Science · doi:10.1126/science.aal3321 · Cited by 2,813 · see citing works

Trends in GPCR drug discovery: new agents, targets and indications

Hauser, A. S., Attwood, M. M., Rask‐Andersen, M., Schiöth, H. B., & Gloriam, D. E. I. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.178 · Cited by 2,609 · see citing works

K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions

Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A., & Shokat, K. M. (2013) · Nature · doi:10.1038/nature12796 · Cited by 2,557 · see citing works

The structure and function of G-protein-coupled receptors

Rosenbaum, D. M., Rasmussen, S. G. F., & Kobilka, B. K. (2009) · Nature · doi:10.1038/nature08144 · Cited by 2,534 · cited 1× · see citing works

A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome

Stelzl, U., Worm, U., Lalowski, M. M., Haenig, C., Brembeck, F. H., Goehler, H., Strödicke, M., Zenkner, M., Schoenherr, A., Koeppen, S., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.029 · Cited by 2,389 · see citing works

eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation

Gingras, A., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,103 · see citing works

A Comprehensive Survey of Ras Mutations in Cancer

Prior, I. A., Lewis, P. D., & Mattos, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2612 · Cited by 2,063 · see citing works

Taxol stabilizes microtubules in mouse fibroblast cells.

Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,971 · see citing works

The atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht

Conte, L. L., Chothia, C., & Janin, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2439 · Cited by 1,967 · see citing works

Reaching for high-hanging fruit in drug discovery at protein–protein interfaces

Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,963 · see citing works

Microtubule-binding agents: a dynamic field of cancer therapeutics

Dumontet, C., & Jordan, M. A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3253 · Cited by 1,730 · see citing works

Protein detection using proximity-dependent DNA ligation assays

Fredriksson, S., Gullberg, M. T., Jarvius, J., Olsson, C., Pietras, K., Gustafsdottir, S., Östman, A., & Landegren, U. D. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-473 · Cited by 1,511 · see citing works

Ras oncogenes: split personalities

Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467 · see citing works

Architecture of the human interactome defines protein communities and disease networks

Huttlin, E. L., Bruckner, R. J., Paulo, J. A., Cannon, J. R., Ting, L., Baltier, K., Colby, G., Gebreab, F., Gygi, M. P., Parzen, H., et al. (2017) · Nature · doi:10.1038/nature22366 · Cited by 1,437 · see citing works

Nitric Oxide Synthases: Properties and Catalytic Mechanism

Griffith, O. W., & Stuehr, D. J. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003423 · Cited by 1,311 · see citing works

Small molecules, big targets: drug discovery faces the protein–protein interaction challenge

Scott, D. E., Bayly, A. R., Abell, C., & Skidmore, J. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.29 · Cited by 1,137 · see citing works

Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality

Arkin, M. R., Tang, Y., & Wells, J. A. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.001 · Cited by 1,065 · see citing works

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

Weitz‐Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J. A., Bruns, C., Cottens, S., Takada, Y., & Hommel, U. (2001) · Nature Medicine · doi:10.1038/89058 · Cited by 1,041 · see citing works

Targeting the PI3K pathway in cancer: are we making headway?

Janku, F., Yap, T. A., & Meric-Bernstam, F. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.28 · Cited by 1,033 · see citing works

Regulation of cap-dependent translation by eIF4E inhibitory proteins

Richter, J. D., & Sonenberg, N. (2005) · Nature · doi:10.1038/nature03205 · Cited by 972 · see citing works

Diversity of protein–protein interactions

Nooren, I. M. A., & Thornton, J. (2003) · EMBO Journal · doi:10.1093/emboj/cdg359 · Cited by 942 · see citing works

Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of Yeast

Hope, I. A., & Struhl, K. (1986) · Cell · doi:10.1016/0092-8674(86)90070-x · Cited by 918 · see citing works

An empirical framework for binary interactome mapping

Venkatesan, K., Rual, J.-F. M., Vázquez, A., Stelzl, U., Lemmens, I. H., Hirozane-Kishikawa, T., Hao, T., Zenkner, M., Xin, X., Goh, K. I., et al. (2008) · Nature Methods · doi:10.1038/nmeth.1280 · Cited by 907 · see citing works

Nitric oxide synthase: Aspects concerning structure and catalysis

Marletta, M. A. (1994) · Cell · doi:10.1016/0092-8674(94)90268-2 · Cited by 862 · see citing works

The structure of protein-protein recognition sites.

Janin, J., & Chothia, C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46181-3 · Cited by 824 · see citing works

Allostery in Disease and in Drug Discovery

Nussinov, R., & Tsai, C. (2013) · Cell · doi:10.1016/j.cell.2013.03.034 · Cited by 764 · see citing works

Hot spots—A review of the protein–protein interface determinant amino‐acid residues

Moreira, I. S., Fernandes, P. A., & Ramos, M. J. (2007) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.21396 · Cited by 760 · see citing works

Protein function in the post-genomic era

Eisenberg, D. S., Marcotte, E. M., Xénarios, I., & Yeates, T. O. (2000) · Nature · doi:10.1038/35015694 · Cited by 749 · see citing works

GAIP and RGS4 Are GTPase-Activating Proteins for the Gi Subfamily of G Protein α Subunits

Berman, D. M., Wilkie, T. M., & Gilman, A. G. (1996) · Cell · doi:10.1016/s0092-8674(00)80117-8 · Cited by 729 · see citing works

Inhibition of α-helix-mediated protein–protein interactions using designed molecules

Azzarito, V., Long, K., Murphy, N. S., & Wilson, A. J. (2013) · Nature Chemistry · doi:10.1038/nchem.1568 · Cited by 727 · see citing works

Methods for the detection and analysis of protein–protein interactions

Berggård, T., Linse, S. S., & James, P. (2007) · PROTEOMICS · doi:10.1002/pmic.200700131 · Cited by 714 · see citing works

Analysis of protein complexes using mass spectrometry

Gingras, A., Gstaiger, M., Raught, B., & Aebersold, R. H. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2208 · Cited by 709 · see citing works

Ras history: The saga continues

Cox, A. D., & Der, C. J. (2010) · Small GTPases · doi:10.4161/sgtp.1.1.12178 · Cited by 706 · see citing works

High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis

Alushin, G. M., Lander, G. C., Kellogg, E. H., Zhang, R., Baker, D., & Nogales, E. (2014) · Cell · doi:10.1016/j.cell.2014.03.053 · Cited by 696 · see citing works

A bioluminescence resonance energy transfer (BRET) system: Application to interacting circadian clock proteins

Xu, Y. Q., Piston, D. W., & Johnson, C. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.151 · Cited by 613 · see citing works

The fibronectin type III domain as a scaffold for novel binding proteins

Koide, A., Bailey, C. W., Huang, X., & Koide, S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2238 · Cited by 585 · see citing works

Dissecting protein–protein recognition sites

Chakrabarti, P., & Janin, J. (2002) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10085 · Cited by 571 · see citing works

Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.

Moerke, N., Aktas, H., Chen, H., Cantel, S., Reibarkh, M., Fahmy, A., Gross, J., Degterev, A., Yuan, J., Chorev, M., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.046 · Cited by 568 · see citing works

Core-binding factors in haematopoiesis and leukaemia

Speck, N. A., & Gilliland, D. G. (2002) · Nature reviews. Cancer · doi:10.1038/nrc840 · Cited by 563 · see citing works

How Ligands Illuminate GPCR Molecular Pharmacology

Wacker, D., Stevens, R. C., & Roth, B. L. (2017) · Cell · doi:10.1016/j.cell.2017.07.009 · Cited by 560 · see citing works

The role of nitric oxide in multiple sclerosis

Smith, K. J., & Lassmann, H. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00102-3 · Cited by 531 · see citing works

Similarity of phylogenetic trees as indicator of protein–protein interaction

Pazos, F., & Valencia, A. (2001) · Protein Engineering Design and Selection · doi:10.1093/protein/14.9.609 · Cited by 521 · see citing works

Modulators of Protein–Protein Interactions

Milroy, L.-G., Grossmann, T. N., Hennig, S., Brunsveld, L., & Ottmann, C. (2014) · Chemical Reviews · doi:10.1021/cr400698c · Cited by 497 · see citing works

Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents

Prota, A. E., Bargsten, K., Zurwerra, D., Field, J. J., Díaz, J. F., Altmann, K., & Steinmetz, M. O. (2013) · Science · doi:10.1126/science.1230582 · Cited by 494 · see citing works

Site-directed ligand discovery

Erlanson, D. A., Braisted, A. C., Raphael, D. R., Randal, M., Stroud, R. M., Gordon, E. M., & Wells, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9367 · Cited by 466 · see citing works

Hydrogen bonds and salt bridges across protein-protein interfaces

Xu, D., Tsai, C.-J., & Nussinov, R. (1997) · Protein Engineering Design and Selection · doi:10.1093/protein/10.9.999 · Cited by 457 · see citing works

The runx genes: gain or loss of function in cancer

Blyth, K., Cameron, E. R., & Neil, J. C. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1607 · Cited by 453 · see citing works

BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.

Lee, F. Y., Borzilleri, R. M., Fairchild, C. R., Kim, S., Long, B. H., Raventós-Suárez, C., Vite, G. D., Rose, W. C., & Kramer, R. A. (2001) · PubMed · Cited by 453 · see citing works

Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia

Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., & Levitt, P. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000866 · Cited by 446 · see citing works

Complex synthetic chemical libraries indexed with molecular tags.

Ohlmeyer, M. H. J., Swanson, R. N., Dillard, L. W., Reader, J. C., Asouline, G., KOBAYASHI, R., Wigler, M. H., & Still, W. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10922 · Cited by 445 · see citing works

Cell-wide analysis of protein thermal unfolding reveals determinants of thermostability

Leuenberger, P., Ganscha, S., Kahraman, A., Cappelletti, V., Boersema, P. J., von Mering, C., Claassen, M., & Picotti, P. (2017) · Science · doi:10.1126/science.aai7825 · Cited by 413 · see citing works

Inhibition of LFA‐1/ICAM‐1 and VLA‐4/VCAM‐1 as a therapeutic approach to inflammation and autoimmune diseases

Yusuf‐Makagiansar, H., Anderson, M. E., Yakovleva, T. V., Murray, J. S., & Siahaan, T. J. (2002) · Medicinal Research Reviews · doi:10.1002/med.10001 · Cited by 408 · see citing works

Mass Spectrometry–Based Proteomics and Network Biology

Bensimon, A., Heck, A. J. R., & Aebersold, R. H. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072909-100424 · Cited by 407 · see citing works

Regulators of G-Protein signalling as new central nervous system drug targets

Neubig, R. R., & Siderovski, D. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd747 · Cited by 403 · see citing works

ASEdb: a database of alanine mutations and their effects on the free energy of binding in protein interactions

Thorn, K. S., & Bogan, A. A. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.3.284 · Cited by 403 · see citing works

A Unified View of “How Allostery Works”

Tsai, C.-J., & Nussinov, R. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003394 · Cited by 401 · see citing works

Targeting protein–protein interactions as an anticancer strategy

Ivanov, A. A., Khuri, F. R., & Fu, H. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.007 · Cited by 401 · see citing works

An Approach to Spatiotemporally Resolve Protein Interaction Networks in Living Cells

Lobingier, B. T., Hüttenhain, R., Eichel, K., Miller, K. B., Ting, A. Y., von Zastrow, M., & Krogan, N. J. (2017) · Cell · doi:10.1016/j.cell.2017.03.022 · Cited by 401 · see citing works

Protein–protein interaction and quaternary structure

Janin, J., Bahadur, R. P., & Chakrabarti, P. (2008) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583508004708 · Cited by 400 · see citing works

Paclitaxel in cancer therapy

Markman, M., & Mekhail, T. M. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.6.755 · Cited by 378 · see citing works

Sequence-based prediction of protein protein interaction using a deep-learning algorithm

Sun, T., Zhou, B., Lai, L., & Pei, J. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1700-2 · Cited by 376 · see citing works

Structure, function, and evolution of transient and obligate protein–protein interactions

Mintseris, J., & Weng, Z. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502667102 · Cited by 373 · see citing works

Ras Conformational Ensembles, Allostery, and Signaling

Lu, S., Jang, H., Muratcioglu, S., Gursoy, A., Keskin, O., Nussinov, R., & Zhang, J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00542 · Cited by 355 · see citing works

Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease

Lee, D. I., Zhu, G., Sasaki, T., Cho, G.-S., Hamdani, N., Holewinski, R., Jo, S.-H., Danner, T., Zhang, M., Rainer, P. P., et al. (2015) · Nature · doi:10.1038/nature14332 · Cited by 353 · see citing works

Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells

Avdulov, S. V., Li, S., Michalek, V. N., Burrichter, D., Peterson, M., Perlman, D., Manivel, J. C., Sonenberg, N., Yee, D., Bitterman, P. B., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.024 · Cited by 341 · see citing works

Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)

Angers, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060590697 · Cited by 341 · see citing works

Calculation of the free energy of association for protein complexes

Horton, N. C., & Lewis, M. (1992) · Protein Science · doi:10.1002/pro.5560010117 · Cited by 329 · see citing works

Allostery: an illustrated definition for the ‘second secret of life’

Fenton, A. W. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.05.009 · Cited by 320 · see citing works

Structure of the negative regulatory domain of p53 bound to S100B(betabeta).

Weber, D. J., Rust, R. R., & Baldisseri, D. M. (2000) · Nature Structural Biology · doi:10.1038/76797 · Cited by 313 · see citing works

Oncogenic protein interfaces: small molecules, big challenges

Nero, T. L., Morton, C. J., Holien, J. K., Wielens, J., & Parker, M. W. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3690 · Cited by 312 · see citing works

Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors

Tracey, W. R., Tse, J., & Carter, G. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24521-9 · Cited by 310 · cited 1× · see citing works

Mechanical Properties of the Cytoskeleton and CellsPreprint

Pegoraro, A. F., Janmey, P. A., & Weitz, D. A. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022038 · Cited by 301 · see citing works

The GRID: The General Repository for Interaction Datasets

Breitkreutz, B., Stark, C., & Tyers, M. (2003) · Genome biology · doi:10.1186/gb-2003-4-3-r23 · Cited by 294 · see citing works

BiGGER: A new (soft) docking algorithm for predicting protein interactions

Palma, P. N., Krippahl, L., Wampler, J. E., & Moura, J. J. G. (2000) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(20000601)39:4 · Cited by 292 · see citing works

Features of protein–protein interactions that translate into potent inhibitors: topology, surface area and affinity

Smith, M. C. P., & Gestwicki, J. E. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2012.10 · Cited by 285 · see citing works

Excitotoxicity and nitric oxide in parkinson's disease pathogenesis

Beal, M. F. (1998) · Annals of Neurology · doi:10.1002/ana.410440716 · Cited by 283 · see citing works

Inhibition of RAS function through targeting an allosteric regulatory site

Spencer-Smith, R., Koide, A., Zhou, Y., Eguchi, R. R., Sha, F., Gajwani, P., Santana, D., Gupta, A., Jacobs, M., Herrero-Garcia, E., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2231 · Cited by 283 · see citing works

Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy

Tan, Z., Xiao, L., Tang, M., Bai, F., Li, J., Li, L., Shi, F., Li, N., Li, Y., Du, Q., et al. (2018) · Theranostics · doi:10.7150/thno.21451 · Cited by 272 · see citing works

Predicting protein-protein interactions on a proteome scale by matching evolutionary and structural similarities at interfaces using PRISM

Tunçbağ, N., Gürsoy, A., Nussinov, R., & Keskin, Ö. (2011) · Nature Protocols · doi:10.1038/nprot.2011.367 · Cited by 264 · see citing works

Coding Nucleotide, 5′ Regulatory, and Deduced Amino Acid Sequences of P-450BM-3, a Single Peptide Cytochrome P-450:NADPH-P-450 Reductase from Bacillus megaterium

Ruettinger, R. T., Wen, L., & Fulco, A. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60416-8 · Cited by 244 · see citing works

Mass spectrometry–based functional proteomics: from molecular machines to protein networks

Köcher, T., & Superti‐Furga, G. (2007) · Nature Methods · doi:10.1038/nmeth1093 · Cited by 240 · see citing works

Emerging Computational Methods for the Rational Discovery of Allosteric Drugs

Wagner, J., Lee, C. T., Durrant, J. D., Malmstrom, R. D., Feher, V. A., & Amaro, R. E. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00631 · Cited by 230 · see citing works

The architecture of functional modules in the Hsp90 co‐chaperone Sti1/Hop

Schmid, A. B., Lagleder, S., Gräwert, M. A., Röhl, A., Hagn, F., Wandinger, S. K., Cox, M. B., Demmer, O., Richter, K., Groll, M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.472 · Cited by 229 · see citing works

Allosite: a method for predicting allosteric sites

Huang, W., Lu, S., Huang, Z., Liu, X., Mou, L., Luo, Y., Zhao, Y., Liu, Y., Chen, Z., Hou, T., et al. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt399 · Cited by 227 · see citing works

The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B

Lu, S., Jang, H., Nussinov, R., & Zhang, J. (2016) · Scientific Reports · doi:10.1038/srep21949 · Cited by 219 · see citing works

Lifitegrast for the Treatment of Dry Eye Disease

Holland, E. J., Luchs, J., Karpecki, P. M., Nichols, K. K., Jackson, M. A., Sall, K. N., Tauber, J., Roy, M., Raychaudhuri, A., & Shojaei, A. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.09.025 · Cited by 218 · see citing works

Analyzing Protein–Protein Interaction Networks

Koh, G. C. K. W., Porras, P., Aranda, B., Hermjakob, H., & Orchard, S. E. (2012) · Journal of Proteome Research · doi:10.1021/pr201211w · Cited by 209 · see citing works

Regulator of G Protein Signaling Proteins: Novel Multifunctional Drug Targets

Zhong, H., & Neubig, R. R. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29606-3 · Cited by 208 · see citing works

Small‐Molecule Stabilization of Protein–Protein Interactions: An Underestimated Concept in Drug Discovery?

Thiel, P., Kaiser, M., & Ottmann, C. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107616 · Cited by 207 · see citing works

PRISM: a web server and repository for prediction of protein–protein interactions and modeling their 3D complexes

Baspinar, A., Cukuroglu, E., Nussinov, R., Keskin, Ö., & Gürsoy, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku397 · Cited by 201 · see citing works

Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry

McMillan, K., Adler, M., Auld, D. S., Baldwin, J. J., Blasko, E., Browne, L. J., Chelsky, D., Davey, D. D., Dolle, R. E., Eagen, K. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1506 · Cited by 200 · see citing works

Targeting Protein-Protein Interaction by Small Molecules

Jin, L., Wang, W., & Fang, G. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-140028 · Cited by 195 · see citing works

Locking in alternate conformations of the integrin αLβ2 I domain with disulfide bonds reveals functional relationships among integrin domains

Lu, C., Shimaoka, M., Zang, Q. S., Takagi, J., & Springer, T. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041618598 · Cited by 192 · see citing works

Cross‐Linking/Mass Spectrometry for Studying Protein Structures and Protein–Protein Interactions: Where Are We Now and Where Should We Go from Here?

Sinz, A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201709559 · Cited by 192 · see citing works

Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view

Lu, S., Jang, H., Gu, S., Zhang, J., & Nussinov, R. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00911a · Cited by 188 · see citing works

Nitric oxide and inflammatory joint diseases

Stichtenoth, D. O., & Frölich, J. C. (1998) · Lara D. Veeken · doi:10.1093/rheumatology/37.3.246 · Cited by 180 · see citing works

Neuronal nitric oxide synthase, a modular enzyme formed by convergent evolution: structure studies of a cysteine thiolate‐liganded heme protein that hydroxylates L‐arginine to produce NO as a cellular signal

Masters, B. S. S., McMillan, K., Sheta, E. A., Nishimura, J. S., Roman, L. J., & Pavel Martasek, E. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.5.8621055 · Cited by 180 · see citing works

Recent advances in microtubule-stabilizing agents

Cao, Y.-N., Zheng, L., Wang, D., Liang, X.-X., Gao, F., & Zhou, X. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.11.062 · Cited by 178 · see citing works

Allosteric Modulator Discovery: From Serendipity to Structure-Based Design

Lu, S., He, X., Ni, D., & Zhang, J. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01749 · Cited by 176 · see citing works

Generation of an LFA-1 Antagonist by the Transfer of the ICAM-1 Immunoregulatory Epitope to a Small Molecule

Gadek, T. R., Burdick, D. J., McDowell, R. S., Stanley, M. S., Marsters, J. C., Paris, K. J., Oare, D. A., Reynolds, M. E., Ladner, C., Zioncheck, K., et al. (2002) · Science · doi:10.1126/science.295.5557.1086 · Cited by 172 · see citing works

Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features

Joaquim Bellmunt, B., Szczylik, C. A., Feingold, J. M., Strahs, A. L., & Berkenblit, A. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn066 · Cited by 170 · see citing works

Allosteric Methods and Their Applications: Facilitating the Discovery of Allosteric Drugs and the Investigation of Allosteric Mechanisms

Lu, S., Shen, Q., & Zhang, J. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.8b00570 · Cited by 166 · see citing works

State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors

Sheng, C., Dong, G., Miao, Z., Zhang, W., & Wang, W. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00252d · Cited by 165 · see citing works

Characterizing Protein–Protein Interactions Using Mass Spectrometry: Challenges and Opportunities

Smits, A. H., & Vermeulen, M. (2016) · Trends in biotechnology · doi:10.1016/j.tibtech.2016.02.014 · Cited by 162 · see citing works

Principles of Allosteric Interactions in Cell Signaling

Nussinov, R., Tsai, C.-J., & Liu, J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja510028c · Cited by 154 · see citing works

The role of the integrin LFA‐1 in T‐lymphocyte migration

Smith, A. M., Stanley, P., Jones, K., Svensson, L. M., McDowall, A., & Hogg, N. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00537.x · Cited by 152 · see citing works

Improved Method for the Identification and Validation of Allosteric Sites

Song, K., Liu, X., Huang, W., Lu, S., Shen, Q., Zhang, L., & Zhang, J. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00014 · Cited by 152 · see citing works

Allosteric sites: remote control in regulation of protein activity

Guarnera, E., & Berezovsky, I. N. (2015) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2015.10.004 · Cited by 149 · see citing works

Harnessing Allostery: A Novel Approach to Drug Discovery

Lu, S., Li, S., & Zhang, J. (2014) · Medicinal Research Reviews · doi:10.1002/med.21317 · Cited by 146 · see citing works

Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug–Target Interactions

Lu, S., & Zhang, J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01844 · Cited by 144 · see citing works

Structure-Based Statistical Mechanical Model Accounts for the Causality and Energetics of Allosteric Communication

Guarnera, E., & Berezovsky, I. N. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004678 · Cited by 141 · see citing works

PARS: a web server for the prediction of Protein Allosteric and Regulatory Sites

Panjkovich, A., & Daura, X. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu002 · Cited by 139 · see citing works

The interaction of Ras with GTPase‐activating proteins

Wittinghofer, A., Scheffzek, K., & Ahmadian, M. R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00321-9 · Cited by 135 · see citing works

Small Molecule Integrin Antagonists that Bind to the β2 Subunit I-like Domain and Activate Signals in One Direction and Block Them in the Other

Shimaoka, M., Salas, A., Yang, W. Y., Weitz‐Schmidt, G., & Springer, T. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00238-3 · Cited by 135 · see citing works

Identification of Small-Molecule Inhibitors of RGS4 Using a High-Throughput Flow Cytometry Protein Interaction Assay

Roman, D. L., Talbot, J. N., Roof, R. A., Sunahara, R. K., Traynor, J. R., & Neubig, R. R. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028670 · Cited by 135 · see citing works

Binding Site Elucidation of Hydantoin-Based Antagonists of LFA-1 Using Multidisciplinary Technologies: Evidence for the Allosteric Inhibition of a Protein−Protein Interaction

Last-Barney, K., Davidson, W. C., Cardozo, M. G., Frye, L. L., Grygon, C. A., Hopkins, J. L., Jeanfavre, D. D., Pav, S., Qian, C., Stevenson, J. M., et al. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0104249 · Cited by 131 · see citing works

Paclitaxel and docetaxel in the treatment of breast cancer

Saloustros, E. S., Mavroudis, D., & Georgoulias, V. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.15.2603 · Cited by 129 · see citing works

AlloSigMA: allosteric signaling and mutation analysis server

Guarnera, E., Tan, Z. W., Zheng, Z., & Berezovsky, I. N. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx430 · Cited by 129 · see citing works

Translating costimulation blockade to the clinic: lessons learned from three pathways

Ford, M. L., & Larsen, C. P. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00776.x · Cited by 123 · see citing works

Recent advances in charting protein–protein interaction: mass spectrometry-based approaches

Gavin, A., Maeda, K., & Kühner, S. (2010) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.09.007 · Cited by 120 · see citing works

Taxol Allosterically Alters the Dynamics of the Tubulin Dimer and Increases the Flexibility of Microtubules

Mitra, A., & Sept, D. (2008) · Biophysical Journal · doi:10.1529/biophysj.108.133884 · Cited by 119 · see citing works

Discovery of hidden allosteric sites as novel targets for allosteric drug design

Lu, S., Ji, M., Ni, D., & Zhang, J. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.10.001 · Cited by 118 · see citing works

A small-molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in mice

Illendula, A., Pulikkan, J. A., Zong, H., Grembecka, J. E., Xue, L., Sen, S., Zhou, Y., Boulton, A. M., Kuntimaddi, A., Gao, Y., et al. (2015) · Science · doi:10.1126/science.aaa0314 · Cited by 114 · see citing works

Allosteric Inhibition of the Protein-Protein Interaction between the Leukemia-Associated Proteins Runx1 and CBFβ

Gorczynski, M. J., Grembecka, J. E., Zhou, Y., Kong, Y., Roudaia, L., Douvas, M. G., Newman, M. N., Bielnicka, I., Baber, G. B., Corpora, T., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.09.006 · Cited by 114 · see citing works

Elevated levels of ΔFosB and RGS9 in striatum in Parkinson’s disease

Tekumalla, P. K., Calon, F., Rahman, Z. U., Birdi, S., Rajput, A. H., Hornykiewicz, O., Paolo, T. D., Bédard, P. J., & Nestler, E. J. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01234-3 · Cited by 110 · see citing works

Cap‐Dependent Translation Initiation Factor e IF4E : An Emerging Anticancer Drug Target

Jia, Y., Polunovsky, V. A., Bitterman, P. B., & Wagner, C. R. (2012) · Medicinal Research Reviews · doi:10.1002/med.21260 · Cited by 109 · see citing works

NMR-Based Approaches for the Identification and Optimization of Inhibitors of Protein–Protein Interactions

Barile, E., & Pellecchia, M. (2014) · Chemical Reviews · doi:10.1021/cr500043b · Cited by 109 · see citing works

Paclitaxel for non-small cell lung cancer

Ramalingam, S., & Belani, C. P. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.8.1771 · Cited by 107 · see citing works

Interrogating the architecture of protein assemblies and protein interaction networks by cross-linking mass spectrometry

Liu, F., & Heck, A. J. R. (2015) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2015.10.006 · Cited by 107 · see citing works

Protein Domain Mimics as Modulators of Protein–Protein Interactions

Sawyer, N., Watkins, A. M., & Arora, P. S. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.7b00130 · Cited by 103 · see citing works

Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye

Zhong, M., Gadek, T. R., Bui, M., Wang, S., Burnier, J. P., Barr, K. J., Hanan, E. J., Oslob, J. D., Yu, C. H., Zhu, J., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml2002482 · Cited by 102 · see citing works

Recent computational advances in the identification of allosteric sites in proteins

Lu, S., Huang, W., & Zhang, J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.07.012 · Cited by 102 · see citing works

Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers

Illendula, A., Gilmour, J., Grembecka, J. E., Tirumala, V. S. S., Boulton, A. M., Kuntimaddi, A., Schmidt, C., Wang, L., Pulikkan, J. A., Zong, H., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.032 · Cited by 100 · see citing works

Peptidomimetic inhibitors of APC–Asef interaction block colorectal cancer migration

Jiang, H., Deng, R., Yang, X., Shang, J., Lu, S., Zhao, Y., Song, K., Liu, X., Zhang, Q., Chen, Y., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2442 · Cited by 100 · see citing works

Role of nitric oxide in the circulatory failure and organ injury in a rodent model of Gram‐positive shock

Kengatharan, K. M., de Kimpe, S. J., & Thiemermann, C. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16053.x · Cited by 99 · see citing works

IntPred: a structure-based predictor of protein–protein interaction sites

Northey, T. C., Barešić, A., & Martin, A. C. R. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx585 · Cited by 98 · see citing works

Alternative modulation of protein–protein interactions by small molecules

Fischer, G., Rossmann, M., & Hyvönen, M. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.04.006 · Cited by 97 · see citing works

Allosteric ligands for G protein-coupled receptors: A novel strategy with attractive therapeutic opportunities

Amici, M. D., Dallanoce, C., Holzgrabe, U., Tränkle, C., & Mohr, K. (2009) · Medicinal Research Reviews · doi:10.1002/med.20166 · Cited by 97 · see citing works

Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4G

Papadopoulos, E., Jenni, S., Kabha, E., Takrouri, K., Yi, T., Salvi, N., Luna, R. E., Gavathiotis, E., Poornachandran, M., Arthanari, H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410250111 · Cited by 96 · see citing works

Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor

Nguyen, T., Li, J., Thomas, B. F., Wiley, J. L., Kenakin, T., & Zhang, Y. (2016) · Medicinal Research Reviews · doi:10.1002/med.21418 · Cited by 95 · see citing works

AlloFinder: a strategy for allosteric modulator discovery and allosterome analyses

Huang, M., Song, K., Liu, X., Lu, S., Shen, Q., Wang, R., Gao, J., Hong, Y., Li, Q., Ni, D., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky374 · Cited by 92 · see citing works

Identification and Characterization of Small Molecule Inhibitors of the Calcium-Dependent S100B−p53 Tumor Suppressor Interaction

Markowitz, J., Chen, I., Gitti, R. K., Baldisseri, D. M., Pan, Y., Udan, R. S., Carrier, F., MacKerell, A. D., & Weber, D. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0497038 · Cited by 91 · see citing works

Discovering cellular protein‐protein interactions: Technological strategies and opportunities

Titeca, K., Lemmens, I. H., Tavernier, J. H., & Eyckerman, S. (2018) · Mass Spectrometry Reviews · doi:10.1002/mas.21574 · Cited by 90 · see citing works

Chemical, Target, and Bioactive Properties of Allosteric Modulation

van Westen, G. J. P., Gaulton, A., & Overington, J. P. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003559 · Cited by 88 · see citing works

Mutation of Gly-11 on the Dimer Interface Results in the Complete Crystallographic Dimer Dissociation of Severe Acute Respiratory Syndrome Coronavirus 3C-like Protease

Chen, S., Hu, T., Zhang, J., Chen, J., Chen, K., Ding, J., Jiang, H., & Shen, X. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705240200 · Cited by 88 · see citing works

The concept of allosteric modulation: an overview

Changeux, J. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.07.007 · Cited by 86 · see citing works

GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site

Lu, S., Banerjee, A., Jang, H., Zhang, J., Gaponenko, V., & Nussinov, R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.664755 · Cited by 86 · see citing works

Small molecule agents targeting the p53‐MDM2 pathway for cancer therapy

Wang, W., & Hu, Y. (2011) · Medicinal Research Reviews · doi:10.1002/med.20236 · Cited by 85 · see citing works

Target-Binding Proteins Based on the 10th Human Fibronectin Type III Domain (10Fn3)

Koide, S., Koide, A., & Lipovšek, D. (2012) · Methods in Enzymology · doi:10.1016/b978-0-12-396962-0.00006-9 · Cited by 84 · see citing works

2P2Idb v2: update of a structural database dedicated to orthosteric modulation of protein–protein interactions

Basse, M.-J., Betzi, S., Morelli, X., & Roche, P. (2016) · Database · doi:10.1093/database/baw007 · Cited by 83 · see citing works

Medicinal Chemistry Strategies to Disrupt the p53–MDM2/MDMX Interaction

Lemos, A., Leão, M., Soares, J., Palmeira, A., Pinto, M. M. M., Saraiva, L., & Sousa, M. E. (2016) · Medicinal Research Reviews · doi:10.1002/med.21393 · Cited by 83 · see citing works

Small Molecule Inhibitors Induce Conformational Changes in the I Domain and the I-like Domain of Lymphocyte Function-associated Antigen-1

Welzenbach, K., Hommel, U., & Weitz‐Schmidt, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110521200 · Cited by 81 · see citing works

Motions of Allosteric and Orthosteric Ligand-Binding Sites in Proteins are Highly Correlated

Ma, X., Meng, H., & Lai, L. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00039 · Cited by 81 · see citing works

Small molecule modulators of protein-protein interactions: selected case studies

Aeluri, M., Chamakuri, S., Dasari, B., Guduru, S. K. R., Jimmidi, R., Jogula, S., & Arya, P. (2014) · Chemical Reviews · doi:10.1021/cr4004049 · Cited by 79 · see citing works

Dendrimer Space Exploration: An Assessment of Dendrimers/Dendritic Scaffolding as Inhibitors of Protein–Protein Interactions, a Potential New Area of Pharmaceutical Development

Mignani, S. M., Kazzouli, S. E., Bousmina, M., & Majoral, J. (2013) · Chemical Reviews · doi:10.1021/cr400362r · Cited by 78 · see citing works

Elucidating the druggable interface of protein−protein interactions using fragment docking and coevolutionary analysis

Bai, F., Morcos, F., Cheng, R. R., Jiang, H., & Onuchic, J. N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615932113 · Cited by 76 · see citing works

Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer

Richardson, D. L., Sill, M. W., Coleman, R. L., Sood, A. K., Pearl, M. L., Kehoe, S. M., Carney, M. E., Hanjani, P., Le, L. V., Zhou, X. C., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.4218 · Cited by 74 · see citing works

Inhibitors of Ras–SOS Interactions

Lu, S., Jang, H., Zhang, J., & Nussinov, R. (2016) · ChemMedChem · doi:10.1002/cmdc.201500481 · Cited by 72 · see citing works

Thinking Outside of the “RGS Box”: New Approaches to Therapeutic Targeting of Regulators of G Protein Signaling

Sjögren, B., & Neubig, R. R. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065219 · Cited by 71 · see citing works

Differential Structural Requirements for Interaction of Ras Protein with Its Distinct Downstream Effectors

Akasaka, K., Tamada, M., Wang, F., Kariya, K.-I., Shima, F., Kikuchi, A., Yamamoto, M., Shirouzu, M., Yokoyama, S., & Kataoka, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5353 · Cited by 69 · see citing works

The Mechanism of ATP-Dependent Allosteric Protection of Akt Kinase Phosphorylation

Lu, S., Deng, R., Jiang, H., Song, H., Li, S., Shen, Q., Huang, W., Nussinov, R., Yu, J., & Zhang, J. (2015) · Structure · doi:10.1016/j.str.2015.06.027 · Cited by 69 · see citing works

Altered affinity of CBFβ-SMMHC for Runx1 explains its role in leukemogenesis

Lukasik, S. M., Zhang, L., Corpora, T., Tomanicek, S., Li, Y., Kundu, M., Hartman, K. L., Liu, P., Laue, T. M., Biltonen, R. L., et al. (2002) · Nature Structural Biology · doi:10.1038/nsb831 · Cited by 67 · see citing works

Stimulation of naïve T‐cell adhesion and immunological synapse formation by chemokine‐dependent and ‐independent mechanisms

Bromley, S. K., & Dustin, M. L. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01441.x · Cited by 63 · see citing works

The Elephant in the Room: The Role of Microtubules in Cancer

Cirillo, L., Gotta, M., & Meraldi, P. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-57127-0_5 · Cited by 63 · see citing works

CBFβ and RUNX1 are required at 2 different steps during the development of hematopoietic stem cells in zebrafish

Bresciani, E., Carrington, B., Wincovitch, S., Jones, M. S., Gore, A. V., Weinstein, B. M., Sood, R. B., & Liu, P. (2014) · Blood · doi:10.1182/blood-2013-10-531988 · Cited by 59 · see citing works

Direct and Propagated Effects of Small Molecules on Protein–Protein Interaction Networks

Cesa, L. C., Mapp, A. K., & Gestwicki, J. E. (2015) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2015.00119 · Cited by 58 · see citing works

Differential Modulation of μ- and δ-Opioid Receptor Agonists by Endogenous RGS4 Protein in SH-SY5Y Cells

Wang, Q., Liu‐Chen, L., & Traynor, J. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.015453 · Cited by 57 · see citing works

Small Molecule Inhibition of the TNF Family Cytokine CD40 Ligand through a Subunit Fracture Mechanism

Silvian, L. F., Friedman, J. E., Strauch, K., Cachero, T. G., Day, E. S., Qian, F., Cunningham, B. C., Fung, A. D., Sun, L., Su, L., et al. (2011) · ACS Chemical Biology · doi:10.1021/cb2000346 · Cited by 57 · see citing works

Microtubule actin cross‐linking factor 1, a novel potential target in cancer

Miao, Z., Ali, A., Hu, L., Zhao, F., Yin, C., Chen, C., Yang, T., & Qian, A. (2017) · Cancer Science · doi:10.1111/cas.13344 · Cited by 57 · see citing works

Identifying Allosteric Hotspots with Dynamics: Application to Inter- and Intra-species Conservation

Clarke, D., Sethi, A., Li, S., Kumar, S., Chang, R. W. F., Chen, J., & Gerstein, M. (2016) · Structure · doi:10.1016/j.str.2016.03.008 · Cited by 56 · see citing works

TOWARDS THE PREDICTION OF COMPLETE PROTEIN–PROTEIN INTERACTION NETWORKS

Gomez, S. M., & Rzhetsky, A. (2001) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789812799623_0039 · Cited by 55 · see citing works

Stabilization of protein–protein interactions by small molecules

Giordanetto, F., Schäfer, A., & Ottmann, C. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.08.005 · Cited by 55 · see citing works

Protein‐protein interactions as antibiotic targets: A medicinal chemistry perspective

Cossar, P. J., Lewis, P. J., & McCluskey, A. (2020) · Medicinal Research Reviews · doi:10.1002/med.21519 · Cited by 55 · see citing works

Designed covalent allosteric modulators: an emerging paradigm in drug discovery

Lu, S., & Zhang, J. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.11.013 · Cited by 53 · see citing works

Recent advances in postmortem pathology and neurochemistry in schizophrenia

Dean, B., Boer, S., Gibbons, A. S., Money, T., & Scarr, E. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328323d52e · Cited by 51 · see citing works

Methods for analyzing and quantifying protein–protein interaction

Syafrizayanti, S., Betzen, C., Hoheisel, J. D., & Kastelic, D. (2014) · Expert Review of Proteomics · doi:10.1586/14789450.2014.875857 · Cited by 51 · see citing works

Discovery and Development of 5-[(5S,9R)-9- (4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1- methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non- 7-yl-methyl]-3-thiophenecarboxylic Acid (BMS-587101)A Small Molecule Antagonist of Leukocyte Function Associated Antigen-1

Potin, D., Launay, M., Monatlik, F., Malabre, P., Fabreguettes, M., Fouquet, A., Maillet, M., Nicolaï, E., Dorgeret, L., Chevallier, F., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0610806 · Cited by 51 · see citing works

The RGS protein inhibitor CCG-4986 is a covalent modifier of the RGS4 Gα-interaction face

Kimple, A. J., Willard, F. S., Giguère, P. M., Johnston, C. A., Mocanu, V., & Siderovski, D. P. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.06.002 · Cited by 50 · see citing works

The Yeast Two-Hybrid System: A Tool for Mapping Protein–Protein InteractionsPreprint

Mehla, J., Caufield, J. H., & Uetz, P. H. (2015) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top083345 · Cited by 50 · see citing works

Deletion of core-binding factor β (Cbfβ) in mesenchymal progenitor cells provides new insights into Cbfβ/Runxs complex function in cartilage and bone development

Wu, M., Li, C., Zhu, G., Wang, Y., Jules, J., Lü, Y., McConnell, M., Wang, Y., Shao, J., Li, Y.-P., et al. (2014) · Bone · doi:10.1016/j.bone.2014.04.031 · Cited by 50 · see citing works

Small Molecule Inhibitors of Regulators of G Protein Signaling (RGS) Proteins

Turner, E. M., Blazer, L. L., Neubig, R. R., & Husbands, S. M. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200263y · Cited by 48 · see citing works

Strategies to Develop Inhibitors of Motif-Mediated Protein-Protein Interactions as Drug Leads

Corbi‐Verge, C., Garton, M., Nim, S., & Kim, P. M. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104805 · Cited by 48 · see citing works

3D-partner: a web server to infer interacting partners and binding models

Chen, Y.-C., Lo, Y., Hsu, W.-C., & Yang, J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm346 · Cited by 46 · see citing works

Therapeutic Antagonists and the Conformational Regulation of the β2 Integrins

Shimaoka, M., & Springer, T. A. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387575 · Cited by 44 · see citing works

Expression of RGS4 Splice Variants in Dorsolateral Prefrontal Cortex of Schizophrenic and Bipolar Disorder Patients

Ding, L., & Hegde, A. N. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.026 · Cited by 43 · see citing works

Small Molecule Antagonist of Leukocyte Function Associated Antigen-1 (LFA-1): Structure−Activity Relationships Leading to the Identification of 6-((5S,9R)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic Acid (BMS-688521)

Watterson, S. H., Xiao, Z., Dodd, D. S., Tortolani, D. R., Vaccaro, W. D., Potin, D., Launay, M., Stetsko, D. K., Skala, S., Davis, P. M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100348u · Cited by 43 · see citing works

Unraveling the molecular mechanism of interactions of the Rho GTPases Cdc42 and Rac1 with the scaffolding protein IQGAP2

Özdemir, E. S., Jang, H., Gürsoy, A., Keskin, Ö., Li, Z., Sacks, D. B., & Nussinov, R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001596 · Cited by 43 · see citing works

Zampanolide and dactylolide: cytotoxic tubulin-assembly agents and promising anticancer leads

Chen, Q., & Kingston, D. G. I. (2014) · Natural Product Reports · doi:10.1039/c4np00024b · Cited by 42 · see citing works

Toward understanding the molecular basis for chemical allosteric modulator design

Wang, Q., Zheng, M., Huang, Z., Liu, X., Zhou, H., Chen, Y., Shi, T., & Zhang, J. (2012) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2012.07.006 · Cited by 40 · see citing works

Allosteric Inhibition of the Regulator of G Protein Signaling–Gα Protein–Protein Interaction by CCG-4986

Roman, D. L., Blazer, L. L., Monroy, C. A., & Neubig, R. R. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.063388 · Cited by 40 · see citing works

Polyplexed Flow Cytometry Protein Interaction Assay: A Novel High-Throughput Screening Paradigm for RGS Protein Inhibitors

Roman, D. L., Ota, S., & Neubig, R. R. (2009) · SLAS DISCOVERY · doi:10.1177/1087057109336590 · Cited by 40 · see citing works

Enabling systematic interrogation of protein–protein interactions in live cells with a versatile ultra-high-throughput biosensor platform

Mo, X., Luo, Y., Ivanov, A. A., Su, R., Havel, J. J., Li, Z., Khuri, F. R., Du, Y., & Fu, H. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv064 · Cited by 40 · see citing works

Bioluminescence Resonance Energy Transfer to Detect Protein-Protein Interactions in Live Cells

Brown, N. E., Blumer, J., & Hepler, J. R. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2425-7_30 · Cited by 37 · see citing works

Conformational Dynamics of a Regulator of G-Protein Signaling Protein Reveals a Mechanism of Allosteric Inhibition by a Small Molecule

Vashisth, H., Storaska, A. J., Neubig, R. R., & Brooks, C. L. (2013) · ACS Chemical Biology · doi:10.1021/cb400568g · Cited by 35 · see citing works

Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions

Wang, X., Ni, D., Liu, Y., & Lu, S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.682675 · Cited by 153 · see citing works

Discovery of cryptic allosteric sites using reversed allosteric communication by a combined computational and experimental strategy

Ni, D., Wei, J., He, X., Rehman, A. U., Li, X., Qiu, Y., Pu, J., Lu, S., & Zhang, J. (2020) · Chemical Science · doi:10.1039/d0sc05131d · Cited by 137 · see citing works

Sequence-based drug design as a concept in computational drug design

Chen, L., Fan, Z., Chang, J., Yang, R., Hou, H., Guo, H., Zhang, Y., Yang, T., Zhou, C., Sui, Q., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39856-w · Cited by 129 · see citing works

Allosteric drugs and mutations: chances, challenges, and necessity

Guarnera, E., & Berezovsky, I. N. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.01.010 · Cited by 117 · see citing works

Structure-Based Stabilization of Non-native Protein–Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design

Lin, S., Lin, S., Hsu, J.-N., Chang, C., Chien, C., Wang, Y., Wu, H., Jeng, U., Kehn‐Hall, K., & Hou, M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01913 · Cited by 108 · see citing works

Strategies for targeting undruggable targets

Zhang, G., Zhang, J., Gao, Y., Li, Y., & Li, Y. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1969359 · Cited by 102 · see citing works

Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators

Lu, S., Chen, Y.-Y., Wei, J., Zhao, M., Ni, D., He, X., & Zhang, J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.09.010 · Cited by 93 · see citing works

New drug discovery and development from natural products: Advances and strategies

Wang, Y., Wang, F., Liu, W., Geng, Y., Shi, Y., Yu, T., Zhang, B., Luo, Y., & Sun, X. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108752 · Cited by 96 · see citing works

Combining Allosteric and Orthosteric Drugs to Overcome Drug Resistance

Ni, D., Li, Y., Qiu, Y., Pu, J., Lu, S., & Zhang, J. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.02.001 · Cited by 91 · see citing works

Fight against novel coronavirus: A perspective of medicinal chemists

Amin, S. A., & Jha, T. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112559 · Cited by 80 · see citing works

Drugging K-RasG12C through covalent inhibitors: Mission possible?

Ni, D., Li, X., He, X., Zhang, H., Zhang, J., & Lu, S. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.06.007 · Cited by 73 · see citing works

Impact of Allosteric Modulation in Drug Discovery: Innovation in Emerging Chemical Modalities

Han, B., Salituro, F. G., & Blanco, M.-J. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00655 · Cited by 74 · see citing works

ASD2023: towards the integrating landscapes of allosteric knowledgebase

He, J., Liu, X., Zhu, C., Zha, J., Li, Q., Zhao, M., Wei, J., Li, M., Wu, C., Wang, J., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad915 · Cited by 68 · see citing works

Along the allostery stream: Recent advances in computational methods for allosteric drug discovery

Ni, D., Chai, Z., Wang, Y., Li, M., Yu, Z., Liu, Y., Lu, S., & Zhang, J. (2021) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1585 · Cited by 67 · see citing works

Small molecules targeting protein–protein interactions for cancer therapy

Wu, D., Li, Y., Zheng, L., Xiao, H., Ouyang, L., Wang, G., & Sun, Q. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.05.035 · Cited by 71 · see citing works

Current Challenges and Opportunities in Designing Protein–Protein Interaction Targeted Drugs

Shin, W., Kumazawa, K., Imai, K., Hirokawa, T., & Kihara, D. (2020) · Advances and Applications in Bioinformatics and Chemistry · doi:10.2147/aabc.s235542 · Cited by 65 · see citing works

Fragment-based drug discovery supports drugging ‘undruggable’ protein–protein interactions

Wang, Z.-Z., Shi, X.-X., Huang, G.-Y., Hao, G., & Yang, G. (2023) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2023.01.008 · Cited by 64 · see citing works

Medicinal Chemistry Strategies for the Development of Bruton’s Tyrosine Kinase Inhibitors against Resistance

Sun, S., Wu, S.-H., Kang, J.-B., Ma, Y.-Y., Chen, L., Cao, P., Chang, L., Ding, N., Xue, X., Li, N., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00030 · Cited by 53 · see citing works

Exploring the Allosteric Territory of Protein Function

Tee, W.-V., Tan, Z. W., Lee, K., Guarnera, E., & Berezovsky, I. N. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c00540 · Cited by 50 · see citing works

Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence

Duran-Frigola, M., Cigler, M., & Winter, G. E. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c11098 · Cited by 50 · see citing works

Design, synthesis, evaluation, and SAR of 4-phenylindoline derivatives, a novel class of small-molecule inhibitors of the programmed cell death-1/ programmed cell death-ligand 1 (PD-1/PD-L1) interaction

Yang, Y., Wang, K., Chen, H., & Feng, Z. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113001 · Cited by 48 · see citing works

Harnessing Reversed Allosteric Communication: A Novel Strategy for Allosteric Drug Discovery

Fan, J., Liu, Y., Kong, R., Ni, D., Yu, Z., Lu, S., & Zhang, J. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01695 · Cited by 41 · see citing works

Computational methods-guided design of modulators targeting protein-protein interactions (PPIs)

Qiu, Y., Li, X., He, X., Pu, J., Zhang, J., & Lu, S. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112764 · Cited by 41 · see citing works

Insight into the mechanism of allosteric activation of PI3Kα by oncoprotein K-Ras4B

Li, X., Dai, J., Ni, D., He, X., Zhang, H., Zhang, J., Fu, Q., Liu, Y., & Lu, S. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.12.020 · Cited by 38 · see citing works

Computational elucidation of allosteric communication in proteins for allosteric drug design

Ni, D., Liu, Y., Kong, R., Yu, Z., Lu, S., & Zhang, J. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.03.012 · Cited by 34 · see citing works

Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications

Zhang, Y., Shan, L., Tang, W., Ge, Y., Li, C., & Zhang, J. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00312 · Cited by 31 · see citing works

The role of genomics and proteomics in drug discovery and its application in pharmacy

Dogiparthi, L. K., Bukke, S. P. N., Thalluri, C., Thalamanchi, B., Vidya, K. P., Sree, G. N., Tatiparthi, H., Uppicherla, D., & Thummaginjala, K. P. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-07155-2 · Cited by 35 · see citing works

Natural allosteric modulators and their biological targets: molecular signatures and mechanisms

Bruder, M., Polo, G., & Trivella, D. B. B. (2020) · Natural Product Reports · doi:10.1039/c9np00064j · Cited by 30 · see citing works

Mechanistic Insights into the Long-range Allosteric Regulation of KRAS Via Neurofibromatosis Type 1 (NF1) Scaffold Upon SPRED1 Loading

Li, M.-Y., Wang, Y., Fan, J., Zhuang, H., Liu, Y., Ji, D., & Lu, S. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167730 · Cited by 31 · see citing works

Self-assembly of peptide nanomaterials at biointerfaces: molecular design and biomedical applications

Guo, X.-Y., Yi, L., Yang, J., An, H., Yang, Z., & Wang, H. (2024) · Chemical Communications · doi:10.1039/d3cc05811e · Cited by 30 · see citing works

Recent advances of β-catenin small molecule inhibitors for cancer therapy: Current development and future perspectives

Yang, P., Zhu, Y., Zheng, Q., Meng, S., Wu, Y., Wen, S., Sun, Q., & Wang, G. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114789 · Cited by 30 · see citing works

Networks of Networks: An Essay on Multi-Level Biological Organization

Uversky, V. N., & Giuliani, A. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.706260 · Cited by 28 · see citing works

Protein–protein interaction and non-interaction predictions using gene sequence natural vector

Zhao, N., Zhuo, M., Tian, K., & Gong, X. (2022) · Communications Biology · doi:10.1038/s42003-022-03617-0 · Cited by 29 · see citing works

Applications of Solution NMR in Drug Discovery

Li, S., & Zhang, N. (2021) · Molecules · doi:10.3390/molecules26030576 · Cited by 26 · see citing works

A Hierarchical Graph Neural Network Framework for Predicting Protein-Protein Interaction Modulators With Functional Group Information and Hypergraph Structure

Zhang, Z., Zhao, L., Wang, J., & Wang, C. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3384238 · Cited by 25 · see citing works

A novel class of selective non-nucleoside inhibitors of human DNA methyltransferase 3A

Huang, S., Stillson, N. J., Sandoval, J. E., Yung, C., & Reich, N. O. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.127908 · Cited by 24 · see citing works

Design, synthesis, and biological evaluation of novel 4,4′-bipyridine derivatives acting as CDK9-Cyclin T1 protein-protein interaction inhibitors against triple-negative breast cancer

Gao, G., Li, J., Cao, Y., Li, X., Qian, Y., Wang, X., Li, M., Qiu, Y., Wu, T., Wang, L., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115858 · Cited by 24 · see citing works

The Potential of Peptide-Based Inhibitors in Disrupting Protein–Protein Interactions for Targeted Cancer Therapy

Afonso, A. L., Cavaleiro, C. T., Castanho, M. A. R. B., Neves, V., & Cavaco, M. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073117 · Cited by 23 · see citing works

Data-driven computational analysis of allosteric proteins by exploring protein dynamics, residue coevolution and residue interaction networks

Astl, L., & Verkhivker, G. M. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.07.008 · Cited by 21 · see citing works

Prediction and targeting of GPCR oligomer interfaces

Barreto, C. A. V., Baptista, S. J., Preto, A. J., Matos‐Filipe, P., Mourão, J., Melo, R., & Moreira, I. S. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.11.007 · Cited by 22 · see citing works

Structure-Based Design of the Indole-Substituted Triazolopyrimidines as New EED–H3K27me3 Inhibitors for the Treatment of Lymphoma

Dong, G., Zuo, J.-H., Yu, J., Xu, J., Gao, G., Li, G., Zhao, W. H., & Yu, B. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c02028 · Cited by 19 · see citing works

Targeting protein-protein interactions with low molecular weight and short peptide modulators: insights on disease pathways and starting points for drug discovery

Trisciuzzi, D., Villoutreix, B. O., Siragusa, L., Baroni, M., Cruciani, G., & Nicolotti, O. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2218641 · Cited by 19 · see citing works

Conformational Selection Mechanism Provides Structural Insights into the Optimization of APC-Asef Inhibitors

He, X., Huang, N., Qiu, Y., Zhang, J., Liu, Y., Yin, X., & Lu, S. (2021) · Molecules · doi:10.3390/molecules26040962 · Cited by 18 · see citing works

Targeting the N-Terminus Domain of the Coronavirus Nucleocapsid Protein Induces Abnormal Oligomerization via Allosteric Modulation

Hsu, J.-N., Chen, J., Lin, S., Hong, J.-Y., Chen, Y.-J., Jeng, U., Luo, S., & Hou, M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.871499 · Cited by 18 · see citing works

Graph Neural Network Model for Prediction of Non-Small Cell Lung Cancer Lymph Node Metastasis Using Protein–Protein Interaction Network and 18F-FDG PET/CT Radiomics

Ju, H., Kim, K., Kim, B. I., & Woo, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020698 · Cited by 17 · see citing works

Microsecond molecular dynamics simulations reveal the allosteric regulatory mechanism of p53 R249S mutation in p53-associated liver cancer

Liu, X., Tian, W., Cheng, J., Li, D., Liu, T., & Zhang, L. (2019) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2019.107194 · Cited by 17 · see citing works

Interface-aware molecular generative framework for protein–protein interaction modulators

Wang, J., Mao, J., Li, C., Xiang, H., Wang, X., Wang, S., Wang, Z., Chen, Y., Li, Y., No, K. T., et al. (2024) · Journal of Cheminformatics · doi:10.1186/s13321-024-00930-0 · Cited by 16 · see citing works

Extended Applications of Small-Molecule Covalent Inhibitors toward Novel Therapeutic Targets

Lee, J., & Park, S. B. (2022) · Pharmaceuticals · doi:10.3390/ph15121478 · Cited by 15 · see citing works

Metadynamics simulations of ligands binding to protein surfaces: a novel tool for rational drug design

Zuo, K., Kranjc, A., Capelli, R., Rossetti, G., Nechushtai, R., & Carloni, P. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d3cp01388j · Cited by 15 · see citing works

Targeting cyclin-dependent kinases: From pocket specificity to drug selectivity

Huang, Y., Liu, W., Zhao, C., Shi, X., Zhao, Q., Jia, J., & Wang, A. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116547 · Cited by 17 · see citing works

In silico identification and experimental validation of long-range allosteric inhibition of Staphylococcus aureus Cas9 catalytic activity by an anti-CRISPR protein AcrIIA14

Wei, J., Chen, F., Lu, X., Fan, J., Li, M., Huang, J., Liu, N., Zhang, J., Chai, Z., & Lu, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143324 · Cited by 14 · see citing works

Large-Scale Crystallographic Fragment Screening Expedites Compound Optimization and Identifies Putative Protein–Protein Interaction Sites

Barthel, T., Wollenhaupt, J., Lima, G. M. A., Wahl, M. C., & Weiss, M. S. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01165 · Cited by 14 · see citing works

Reliable prediction of cannabinoid receptor 2 ligand by machine learning based on combined fingerprints

Zhou, H., Shan, M., Qin, L., & Cheng, G. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106379 · Cited by 13 · see citing works

Autopromotion of K-Ras4B Feedback Activation Through an SOS-Mediated Long-Range Allosteric Effect

He, X., Du, K., Wang, Y., Fan, J., Li, M., Ni, D., Lu, S., Bian, X., & Liu, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.860962 · Cited by 13 · see citing works

HBCVTr: an end-to-end transformer with a deep neural network hybrid model for anti-HBV and HCV activity predictor from SMILES

Meewan, I., Panmanee, J., Petchyam, N., & Lertvilai, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-59933-4 · Cited by 13 · see citing works

Molecular characterization of COVID-19 therapeutics: luteolin as an allosteric modulator of the spike protein of SARS-CoV-2

Alvarado, W., Pérez-Lemus, G. R., Menéndez, C. A., Byléhn, F., & Pablo, J. (2021) · Molecular Systems Design & Engineering · doi:10.1039/d1me00119a · Cited by 13 · see citing works

Handling complexity in biological interactions

Vega, S., Abián, O., & Velázquez‐Campoy, A. (2019) · Journal of Thermal Analysis and Calorimetry · doi:10.1007/s10973-019-08610-0 · Cited by 13 · see citing works

Allosteric inhibition of myosin by phenamacril: a synergistic mechanism revealed by computational and experimental approaches

Bao, Y., Xu, Y., Jia, F., Li, M., Xu, R., Zhang, F., & Guo, J. (2023) · Pest Management Science · doi:10.1002/ps.7699 · Cited by 12 · see citing works

Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1

Hu, K., Li, X., Asmamaw, M. D., Shi, X., & Liu, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-00646-3 · Cited by 12 · see citing works

Biophysical Insight into the SARS-CoV2 Spike–ACE2 Interaction and Its Modulation by Hepcidin through a Multifaceted Computational Approach

Hadi‐Alijanvand, H., Paola, L. D., Hu, G., Leitner, D. M., Verkhivker, G. M., Sun, P., Poudel, H., & Giuliani, A. (2022) · ACS Omega · doi:10.1021/acsomega.2c00154 · Cited by 12 · see citing works

Probing GPCR Dimerization Using Peptides

Farooq, Z., Howell, L. A., & McCormick, P. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.843770 · Cited by 10 · see citing works

Assessing the binding properties of <scp>CASP14</scp> targets and models

Egbert, M., Ghani, U., Ashizawa, R., Kotelnikov, S., Nguyen, T., Desta, I., Hashemi, N., Padhorny, D., Kozakov, D., & Vajda, S. (2021) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.26209 · Cited by 10 · see citing works

Role of protein-protein interactions in allosteric drug design for DNA methyltransferases

Liang, Z. T., Zhu, Y., Liu, X., & Hu, G. (2020) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.12.005 · Cited by 10 · see citing works

Natural Product Modulators of Protein–Protein Interactions: A Comprehensive Review

Kamel, E. M., Allam, A. A., Rudayni, H. A., Alkhayl, F. F. A., Ahmed, N. A., & Lamsabhi, A. M. (2026) · Phytochemical Analysis · doi:10.1002/pca.70054 · Cited by 9 · see citing works

Effects of Homogeneous and Heterogeneous Crowding on Translational Diffusion of Rigid Bovine Serum Albumin and Disordered Alfa-Casein

Kusova, A. M., Rakipov, I. T., & Zuev, Y. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311148 · Cited by 8 · see citing works

A Structure-Based Allosteric Modulator Design Paradigm

Li, M., Lan, X., Lu, X., & Zhang, J. (2023) · Health Data Science · doi:10.34133/hds.0094 · Cited by 7 · see citing works

Accommodating Statistical and Physics-Based Computational Protocols for Molecular Glue Model and Evaluation

Xu, Q., Liu, W., Liu, H., & Zheng, Z. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00387 · Cited by 8 · see citing works

Protein-protein complexes as targets for drug discovery against infectious diseases

Akhter, Y., & Hussain, R. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.11.012 · Cited by 7 · see citing works

Molecular Insights into the Heterotropic Allosteric Mechanism in Cytochrome P450 3A4-Mediated Midazolam Metabolism

Fu, T., Zhang, H., & Zheng, Q. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01264 · Cited by 7 · see citing works

Mechanistic insights into the role of calcium in the allosteric regulation of the calmodulin-regulated death-associated protein kinase

Li, X., Li, B., Li, J., Yang, M., Bai, Y., Chen, K., Chen, K., & Mao, N. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1104942 · Cited by 6 · see citing works

Unraveling the therapeutic potential of Senna singueana phytochemicals to attenuate pancreatic cancer using protein–protein interactions, molecular docking, and MD simulation

Balkrishna, A., Sharma, D., Thapliyal, M., Arya, V., & Dabas, A. (2023) · In Silico Pharmacology · doi:10.1007/s40203-023-00179-9 · Cited by 6 · see citing works

Förster Resonance Energy Transfer Measurements in Living Bacteria for Interaction Studies of BamA with BamD and Inhibitor Identification

Schreiber, S., & Jose, J. (2024) · Cells · doi:10.3390/cells13221858 · Cited by 5 · see citing works

A Bridge to Alkaloid Synthesis

Zhai, L., Tang, Y. H., Zhang, Y., Huang, S., Zhu, L., & Hong, R. (2021) · The Chemical Record · doi:10.1002/tcr.202100197 · Cited by 5 · see citing works

Descoberta de fármacos a partir de produtos naturais e a abordagem Molecular Power House (MPH)

Trivella, D. B. B., Bruder, M., Oliveira, F. C. B., Porcaro, R., Rustiguel, J. K. R., Ribeiro, L. B., de Felício, R., da Cunha, M. G., Nascimento, A. F. Z., Zeri, A. C. D. M., et al. (2022) · Revista Fitos · doi:10.32712/2446-4775.2022.1346 · Cited by 5 · see citing works

Exploration of the selective binding mechanism of GSK3β via molecular modeling and molecular dynamics simulation studies

Mou, L., Ma, Z., Meng, X., Li, W., Liang, S., & Chen, X. (2020) · Medicinal Chemistry Research · doi:10.1007/s00044-020-02514-7 · Cited by 5 · see citing works

Uncovering molecular determinants of potency and binding affinity in hit compounds targeting FGF14/Nav1.6 complex

Teimouri, H., Haghighijoo, Z., Baumgartner, T. J., Singh, A. K., Wadsworth, P. A., Zhang, C., Chen, H., Zhou, J., & Laezza, F. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-01122-0 · Cited by 4 · see citing works

Directional Engineering of Cyclic β-Hairpin Peptides for PET/CT Imaging of PD-L1

Liu, C., Zhang, S., Chen, J., Geng, H. R., Li, H., Zhang, Z., Lu, Q., Xu, L., Li, J., Zhang, H., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c21595 · Cited by 4 · see citing works

Advanced nanotechnologies for protein modulation: From Nano-PROTAC to Nano-APROM

Wang, J., Hu, X., Zhang, J., Wang, C., Dai, H., Lu(杨露), Y., Li, F., & Ling, D. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114901 · Cited by 4 · see citing works

Computational investigation of a ternary model of SnoN-SMAD3-SMAD4 complex

Ji, M., Ding, Y., Li, X., Mao, N., & Chen, J. (2019) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2019.107159 · Cited by 4 · see citing works

Interaction of Isocitrate Lyase with Proteins Involved in the Energetic Metabolism in Paracoccidioides lutzii

Silva, K. S. F. E., Lima, R. M., Lima, P. D. S., Baeza, L. C., da Silva, R. A., Soares, C. M. D. A., & Pereira, M. (2020) · Journal of Fungi · doi:10.3390/jof6040309 · Cited by 4 · see citing works

Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation–Drug leads for metastatic castration resistant prostate cancer

Fancher, A. T., Hua, Y., Close, D. A., Xu, W., McDermott, L. A., Strock, C. J., Santiago, U., Camacho, C. J., & Johnston, P. A. (2023) · SLAS DISCOVERY · doi:10.1016/j.slasd.2023.08.001 · Cited by 4 · see citing works

Modulating Target Protein Biology Through the Re-mapping of Conformational Distributions Using Small Molecules

Lawson, A. D. G., MacCoss, M., Baeten, D., Macpherson, A., Shi, J., & Henry, A. J. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.668186 · Cited by 4 · see citing works

Where to next in the evolution of in silico design of modulators targeting protein–protein interactions?

Wang, Y., & Wang, X. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2198699 · Cited by 4 · see citing works

Discovery of Bioactive Peptides Through Peptide Scanning

Iaculli, D., & Ballet, S. (2025) · Journal of Peptide Science · doi:10.1002/psc.70029 · Cited by 3 · see citing works

Advancements in Loop Cyclization Approaches for Enhanced Peptide Therapeutics for Targeting Protein–Protein Interactions

Lombardi, L., Granger, L. A., Shattock, R. J., & Williams, D. R. (2024) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.4c02178 · Cited by 3 · see citing works

Dual-fluorescent bacterial two-hybrid system for quantitative Protein–Protein interaction measurement via flow cytometry

Wu, L., Su, L., Deng, M., Hong, X., Wu, M., Zhang, M., Bouveret, E., & Yan, X. (2021) · Talanta · doi:10.1016/j.talanta.2021.122549 · Cited by 3 · see citing works

Discovery of bromobenzyl phenyl ether derivative YPD-29B: a novel pre-clinical compound targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction

Yang, Y., Xu, M., Wang, K., Xia, L., Ning, Q., Wu, X., Zang, X., Lai, F., Chen, X., & Feng, Z. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118366 · Cited by 1 · see citing works

Computational Structural Modeling to Discover PPI Modulators

Yang, X., & Ivanov, A. A. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016544-00087 · Cited by 1 · see citing works

Fertility and early embryonic development toxicity and toxicokinetic study of KFP‐H008 in Sprague–Dawley rats

Lu, B., Peng, Y., Shao, Q., Mao, L., & Qiao, H. (2022) · Birth Defects Research · doi:10.1002/bdr2.2002 · Cited by 1 · see citing works

p‐Chloropropynyl Phenylalanine, a Versatile Non‐Canonical Amino Acid for Co‐Translational Peptide Macrocyclization and Side Chain Diversification

Franco, H. E. O., Le, A. V., Chang, N. Y., & Hartman, M. C. T. (2023) · ChemBioChem · doi:10.1002/cbic.202300020 · Cited by 1 · see citing works

Effective and transient mapping of protein–protein interactions: Application of novel releasable photoaffinity linkers

Wang, J., Ma, Y., Li, J., Zhang, Q., Pan, X., Lu, W. Z., & Zhang, J. (2021) · Drug Development Research · doi:10.1002/ddr.21866 · Cited by 1 · see citing works

Drug design and repurposing with a sequence-to-drug paradigmPreprint

Chen, L., Fan, Z., Chang, J., Yang, R., Guo, H., Zhang, Y., Yang, T., Zhou, C., Chen, Z., Zheng, C., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.26.485909 · Cited by 1 · see citing works

Handling complexity in biological interactions: Allostery and cooperativity in proteins

Vega, S., Abián, O., & Velázquez‐Campoy, A. (2019) · DIGITAL.CSIC (Spanish National Research Council (CSIC))

Assay Development and High‐Throughput Screening

Carettoni, D., & Bader, B. (2021) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc165.pub2

(FAB01_033) The English Benedictine Connection - The Works of Charles Hansom in Australia

Andrews, B. (1989) · Fabrications

Allosteric Modulation

Doller, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00057-8

Research progress in small-molecule modulators of protein-protein interactions

Yang, B., & Qi, X. (2023) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-0034

Multi-scale Global Consistency Residue Feature Enhancement based Protein Structure Analysis

Li, Q., Du, B. Q., Qin, X. L., Zhang, J., & Xu, S. B. (2023) · International Conference on Communication and Information Processing (ICCIP) · doi:10.1145/3638884.3638889

Network biology and bioinformatics-based framework to identify the impacts of SARS-CoV-2 infections on lung cancer and tuberculosisPreprint

Waaje, A., Sarkar, M. S., & Islam, M. Z. (2024) · medRxiv · doi:10.1101/2024.09.10.24313452

Trends Assessment of the Genetic Mutation Induced Protein-Protein Interaction Variation via Protein Large Language Driven MethodPreprint

Kuang, Z.-J., Li, Y.-K., Liu, Z., Zhao, J., Shi, L.-J., Akira-Kawai, & Wang, H. (2025) · bioRxiv · doi:10.1101/2025.05.23.655070

Allosteric Modulators of Protein–Protein Interactions (PPIs)

Ni, D., Liu, N., & Sheng, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8719-7_13 · Cited by 37 · see citing works

Harnessing Allostery to Modulate Protein–Protein Interactions: From Function to Therapeutic Innovations

Mukhopadhyay, S., Sinha, K., & Chakrabarty, S. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169382 · Cited by 10 · see citing works

Computational Structural Modeling to Discover PPI Modulators

Yang, X., & Ivanov, A. A. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016544-00087 · Cited by 1 · see citing works

Alternative modulation of protein–protein interactions by small molecules

Fischer, G., Rossmann, M., & Hyvönen, M. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.04.006 · Cited by 97 · see citing works

Computational methods-guided design of modulators targeting protein-protein interactions (PPIs)

Qiu, Y., Li, X., He, X., Pu, J., Zhang, J., & Lu, S. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112764 · Cited by 41 · see citing works